With few specifics, Recursion underwhelms with first Phase 2 readout, but ‘plans to advance’ drug Endpoints NewsRecursion presents mixed data on lead AI-derived drug candidate for potentially fatal brain condition STATNvidia-backed Recursion hurts AI biotechs on mixed data for lead drug Seeking AlphaRecursion Pharmaceuticals Stock Is Sliding Tuesday: What’s Going On? BenzingaRecursion’s phase 2 brain disease trial yields scant evidence of efficacy Fierce Biotech
Friday, November 15, 2024
YOUR COUNTRY MUSIC STATION FOR HAYWOOD COUNTY NORTH CAROLINA